Renowned regulatory expert and D.C. lobbyist Tami Wahl joins us to lend her perspective on the future of hemp extracts and the FDA.
Will the FDA finally allow for CBD in supplements?
What could change under the Biden administration?
How do New York's new regulations influence decision making at the federal level?
